Clinical Trial Update: ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating ONC201 in combination with atezolizumab for obesity-driven endometrial cancer, currently recruiting and including several…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinosarcoma of the Endometrium
• Clear Cell Endometrial Carcinoma
• Endometrial Cancer
• Endometrial Mixed Adenocarcinoma
• Endometrioid Endometrial Adenocarcinoma
• Serous Endometrial Adenocarcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• ONC201 (ONC201)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Endometrial Cancer, Metastasis | Phase 1 | Status: RECRUITING